Lexeo Therapeutics, Inc. — Investor Relations & Filings
Lexeo Therapeutics, Inc. is a clinical-stage genetic medicine company dedicated to developing gene therapies for genetically defined diseases. The company is advancing a diverse pipeline of investigational adeno-associated virus (AAV)-based gene therapy candidates. Its primary areas of focus are rare cardiovascular diseases and APOE4-associated Alzheimer's disease. Lexeo's strategy centers on addressing conditions with high unmet medical needs by leveraging pioneering science, including research originating from institutions such as Weill Cornell Medicine, to develop treatments with curative potential.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-05-11 | English | |
| 8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-05-11 | English | |
| ARS - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-04-30 | English | |
| DEF 14A - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-04-30 | English | |
| 8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-04-30 | English | |
| 10-K - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-03-30 | English |
Browse filings by year
5 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Hangzhou Tianmushan Pharmaceutical Enterprise Co.,Ltd
Produces TCM, chemical drugs, and health supplements for di…
|
600671 | CN | Manufacturing |
|
Hanmi Pharm. Co., Ltd.
A research-oriented biopharmaceutical company developing an…
|
128940 | KR | Manufacturing |
|
Hanmi Science Co.,Ltd
A holding company managing subsidiaries in the pharmaceutic…
|
008930 | KR | Manufacturing |
|
Hansa Biopharma
Develops antibody-cleaving enzyme technology for rare immun…
|
HNSA | SE | Manufacturing |
|
Hansoh Pharmaceutical Group Company Limited
Leading innovation-driven biopharmaceutical enterprise deve…
|
3692 | KY | Manufacturing |
|
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Clinical-stage biopharma developing immuno-oncology therapi…
|
3378 | HK | Manufacturing |
|
Harbin Fuerjia Technology Co., Ltd.
Develops medical dressings and functional cosmetics for ski…
|
301371 | CN | Manufacturing |
|
HARBIN GLORIA PHARMACEUTICALS Co., LTD
Develops and produces drugs for cardiovascular, orthopedic,…
|
002437 | CN | Manufacturing |
|
HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.
Produces injections and oral drugs for cardiovascular, gast…
|
002900 | CN | Manufacturing |
|
Harbin Pharmaceutical Group Co.,Ltd.
Researches and manufactures pharmaceuticals, OTC drugs, and…
|
600664 | CN | Manufacturing |
Lexeo Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33133/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33133 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33133 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33133 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33133}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lexeo Therapeutics, Inc. (id: 33133)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.